BioNexus Gene Lab BGLC
NASDAQ BGLC
$1.19 -0.01 (-1.24%)
At close: Oct 21, 2026 · 4:00 PM EDT

BioNexus Gene Lab (BGLC) Share-based Compensation (2023 - 2025)

Updated

BioNexus Gene Lab's Share-based Compensation came in at $794,770 for Q4 2025.

Analysis

BioNexus Gene Lab (BGLC) Share-based Compensation (2023 - 2025) Analysis & Trends

  • Going back by year, Share-based Compensation was $141,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 United Rentals 66.79 Bn 65.55 Bn 1.73 Bn 43.00 Mn
2 W.W. Grainger 63.72 Bn 61.32 Bn 1.98 Bn 25.00 Mn
3 Fastenal 60.28 Bn 59.28 Bn 1.10 Bn 2.60 Mn
4 Ferguson Enterprises 44.38 Bn 41.59 Bn 2.32 Bn 16.00 Mn
5 Sunbelt Rentals Holdings 32.28 Bn 32.16 Bn 1.25 Bn 26.00 Mn
6 Reliance 21.45 Bn 20.49 Bn 1.30 Bn 23.40 Mn
7 Wesco International 17.03 Bn 14.34 Bn 1.46 Bn 19.10 Mn
8 Applied Industrial Technologies 12.67 Bn 12.54 Bn 411.22 Mn 1.97 Mn
9 Avantor 11.71 Bn 10.50 Bn 537.00 Mn 15.40 Mn
10 BioNexus Gene Lab 2.23 Mn -5.14 Mn 12,982.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 794,770.00
Dec 31, 2023 -90,001.00
API Access

BioNexus Gene Lab Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BGLC&period=max&api_key=YOUR_API_KEY